sinc
advent
crosssect
magnet
reson
mr
comput
tomographi
ct
imag
techniqu
diagnosi
character
variou
intracrani
infecti
process
advanc
significantli
specif
imag
characterist
differ
pathogen
thoroughli
describ
repres
first
step
manag
followup
patient
structur
crosssect
techniqu
howev
reach
limit
question
molecular
natur
ask
differenti
activ
infect
steril
inflamm
andor
immun
respons
etiolog
primari
metastat
malign
figur
molecular
imag
hand
potenti
transcend
limit
structur
imag
provid
molecular
cellular
level
inform
multipl
exampl
preclin
central
nervou
system
cn
imag
applic
set
viral
bacteri
parasit
fungal
infect
found
literatur
clinic
human
translat
applic
howev
remain
limit
number
scope
optic
imag
petspect
imag
two
commonli
use
molecular
imag
modal
anim
model
cn
infect
studi
attempt
target
unmodifi
pathogen
directli
track
genet
modifi
pathogen
anim
model
gener
use
optic
imag
remain
main
approach
also
multipl
studi
describ
host
respons
infect
activ
microglia
compon
immun
system
among
approach
direct
target
pathogen
probabl
clinic
signific
would
interest
translat
target
pathogen
limit
lack
pathogenspecif
imag
ligand
anoth
limit
inher
cn
presenc
barrier
limit
brain
access
molecul
special
characterist
eg
small
size
appropri
lipophil
even
though
bbb
disrupt
infecti
process
alway
case
fact
indol
less
aggress
pathogen
bbb
remain
intact
minim
breach
theori
directli
imag
infecti
agent
perform
use
ligand
incorpor
pathogen
eukaryot
cell
target
pathogen
enzym
label
substrat
one
exampl
latter
approach
imag
herpet
enceph
use
fluorin
deriv
ganciclovir
select
phosphoryl
hsv
thymidin
kinas
tk
enzym
subsequ
trap
within
infect
cell
select
uptak
ligand
visual
use
pet
imag
rat
receiv
intranas
inject
compar
sham
anim
approach
howev
limit
pathogen
possess
tk
enzym
importantli
inabl
tk
substrat
fhpg
fhbg
fiau
cross
intact
bbb
even
bbb
disrupt
substrat
leak
result
nonspecif
accumul
welldesign
experi
buursma
et
al
use
freez
injuri
model
caus
steril
disrupt
bbb
even
though
accumul
initi
wash
quickli
suggest
fhpg
uptak
actual
infect
due
irrevers
trap
ligand
phosphoryl
form
within
infect
cell
anoth
recent
describ
ligand
fluorodeoxysorbitol
depend
select
uptak
bacteria
case
enterobacteriacea
famili
gramneg
bacteria
sorbitol
taken
eukaryot
cell
found
readili
incorpor
gramneg
gramposit
bacteri
cell
previous
synthes
chemic
reduct
wide
avail
ligand
even
though
origin
design
imag
brain
tumor
significantli
higher
uptak
seen
e
coliinfect
brain
versu
brain
tumor
normal
brain
suggest
specif
uptak
retent
bacteria
figur
render
even
sensit
demonstr
lack
background
uptak
normal
brain
even
though
fd
detect
infect
due
enterobacteriacea
famili
greatli
use
right
clinic
set
provid
local
infect
differenti
activ
infect
host
inflammatori
reaction
evalu
respons
treatment
develop
pathogenspecif
ligand
wider
detect
rang
low
background
uptak
ultim
goal
much
commonli
seen
direct
pathogen
detect
brain
molecular
imag
use
genet
modifi
pathogen
traceabl
report
gene
mechan
common
approach
use
recombin
virus
engin
express
luciferas
enzym
allow
perform
longitudin
imag
accur
determin
site
infect
describ
tempor
system
dissemin
viru
eventu
quantifi
viral
titer
variou
organ
major
limit
howev
inher
potenti
attenu
viral
replic
andor
loss
virul
pathogen
latter
factor
thu
need
care
evalu
prior
start
imag
experi
earli
exampl
includ
develop
recombin
virus
express
variou
luciferas
report
protein
vaccinia
viru
mous
hepat
viru
mhv
member
coronaviru
famili
interest
find
paper
raaben
et
al
detect
protect
role
type
interferon
mhv
infect
widespread
viral
dissemin
elucid
bioluminesc
seen
mice
lack
function
type
interferon
respons
revers
process
administr
type
interferon
mice
exampl
molecular
imag
provid
insight
potenti
therapeut
applic
recent
exampl
includ
use
recombin
murin
gammaherpesviru
express
firefli
luciferas
fluc
monitor
viru
progress
cn
infect
recombin
realtim
evalu
replic
kinet
brain
infect
mice
western
equin
enceph
viru
weev
alphaviru
mosquitoborn
viru
caus
sever
enceph
human
also
evalu
recombin
form
express
fluc
intranas
infect
mice
genet
engin
report
gene
approach
howev
limit
virus
use
pathogen
parasit
genet
modifi
fulli
virul
african
trypanosoma
vivax
strain
stabli
express
fluc
monitor
vivo
brain
infect
immunocompet
mice
light
emit
brain
increas
slightli
till
day
postinfect
background
rose
substanti
day
reach
background
thu
provid
evid
parenchym
infiltr
exampl
report
gene
use
includ
imag
toxoplasma
gondii
enceph
spatiotempor
demonstr
recrudesc
infect
cn
immunocompromis
mice
virul
recombin
pathogen
also
use
assess
respons
treatment
exampl
strain
modifi
integr
luminesc
lux
operon
use
determin
respons
infect
daptomycin
altern
antibiot
eventu
found
effect
vancomycin
similarli
use
luciferaseexpress
trypanosoma
brucei
brucei
allow
identif
pathogen
entri
brain
use
multiphoton
microscopi
earli
stage
determin
respons
variou
drug
bioluminesc
parasit
perman
elimin
treatment
melarsoprol
diminazen
interest
find
paper
investig
wait
clinic
develop
encephalit
stage
diseas
could
take
late
day
initi
stage
infect
instead
use
serial
noninvas
bioluminesc
imag
reduc
time
need
assess
drug
efficaci
twothird
altern
model
report
geneexpress
pathogen
genet
modifi
anim
model
usual
mice
exampl
luker
et
al
develop
transgen
report
mous
use
promot
thymidin
kinas
control
express
fluc
exposur
three
differ
strain
test
would
activ
express
fluc
bioluminesc
increas
proport
increas
input
titer
viru
studi
howev
detect
brain
involv
complex
model
transgen
report
mous
strain
express
fluc
regulatori
control
concaten
promot
transgen
report
mous
luciferas
express
driven
nuclear
factor
b
nfb
depend
portion
human
immunodefici
long
termin
repeat
ltr
allow
visual
brain
luciferas
express
respons
adenoviru
infect
lp
intraperiton
inject
respect
particularli
interest
exampl
combin
two
approach
report
gene
report
mous
use
streptococcu
pneumonia
strain
engin
bioluminesc
lux
transgen
mous
model
contain
induc
fluc
report
gene
transcript
control
mous
glial
fibrillari
acid
protein
gfap
promot
two
report
separ
base
differ
spectra
light
emiss
substrat
requir
lux
fluc
use
highli
sensit
vivo
imag
system
approach
allow
monitor
diseas
progress
respons
treatment
one
hand
document
brain
damag
time
indirect
way
imag
sequela
intracrani
infect
imag
host
reaction
perhap
commonli
use
approach
set
imag
infectionassoci
neuroinflamm
achiev
target
transloc
protein
tspo
outer
mitochondri
membran
receptor
get
upregul
activ
microglia
astrocyt
blood
deriv
macrophag
respons
cn
central
nervou
system
injuri
classic
ligand
tspo
alway
howev
multitud
newer
secondgener
ligand
design
overcom
limit
develop
last
coupl
decad
use
two
secondgener
ligand
along
prototyp
ligand
neuroinflamm
set
hsv
enceph
could
imag
show
lowest
nonspecif
uptak
suggest
may
suitabl
visual
mild
inflamm
pathogen
neuroinflamm
visual
use
tspo
ligand
includ
simian
immunodefici
viru
siv
macaqu
taenia
solium
neurocysticercosi
patient
latter
studi
perilesion
edema
surround
calcifi
lesion
visual
use
suggest
resurg
inflamm
despit
chronic
infecti
process
major
limit
tspo
imag
howev
exist
main
limit
inabl
specif
visual
infect
ligand
accumul
readili
seen
steril
inflamm
induc
inject
quinolin
acid
rat
striatum
figur
anoth
main
limit
human
translat
tspo
imag
recent
describ
polymorph
locat
exon
tspo
gene
result
nonconserv
amino
acid
substitut
posit
alanin
threonin
fifth
transmembran
domain
tspo
protein
polymorph
result
three
bind
level
high
medium
low
bind
account
variabl
case
genotyp
subject
prior
quantit
assess
tspo
upregul
use
pet
necessari
anoth
problem
tspo
imag
nonfoc
brain
infect
neurohiv
lack
refer
region
due
diffus
involv
brain
analysi
data
case
requir
laborintens
arteri
blood
sampl
analysi
metabolit
recent
descript
tspo
ligand
sensit
polymorph
encourag
current
evalu
neuroinflamm
imag
target
includ
cannabinoid
receptor
togeth
constitut
endocannabinoid
system
multipl
ligand
target
develop
encourag
anim
applic
target
leukocyt
platelet
chang
associ
differ
infecti
process
also
attempt
one
exampl
use
singlechain
antibodi
recogn
ligandinduc
bind
site
lib
gpiibiiia
activ
platelet
gpiibiiia
becom
expos
upon
activ
therefor
offer
opportun
target
activ
platelet
conjug
lib
antibodi
iron
oxid
nanoparticl
use
anim
model
cerebr
malaria
abl
detect
abnorm
vascular
platelet
aggreg
vivo
approach
allow
imag
infect
patholog
could
visual
convent
vivo
mri
offshoot
optic
imag
twophoton
microscopi
open
door
better
understand
pathogenhost
interact
brain
till
hand
studi
use
technolog
evalu
infecti
process
howev
avail
literatur
point
toward
big
role
techniqu
better
understand
role
specif
immun
cell
cd
lymphocyt
antigenpres
cell
apc
pathophysiolog
cn
infect
potenti
applic
limitless
exampl
brain
mice
chronic
infect
twophoton
microscopi
show
antigen
ag
specif
cell
recruit
persist
presenc
ongo
ag
recognit
dynam
interact
cell
parasit
could
visual
real
time
cell
made
transient
contact
granulomalik
structur
contain
parasit
individu
apc
includ
contain
parasit
ignor
intact
agbear
cyst
astrocyt
neuron
includ
infect
neuron
anoth
exampl
twophoton
imag
use
mice
infect
differ
strain
malaria
show
cell
tend
accumul
mainli
perivascular
space
experiment
cerebr
malaria
ecm
mice
howev
also
seen
strain
caus
ecm
indic
presenc
perivascular
cell
per
se
insuffici
caus
ecm
differenti
strain
howev
dynam
timelaps
movi
show
distinct
differ
tcell
motil
rather
local
arrest
cell
perivascular
space
correl
pathogen
potenti
dynam
realtim
demonstr
immun
system
interact
within
live
tissu
sure
facilit
improv
understand
immun
respons
persist
pathogen
brain
imag
infect
cn
handl
use
crosssect
imag
two
decad
result
larg
array
descript
diagnost
criteria
capabl
circumst
narrow
differenti
diagnosi
detect
lifethreaten
complic
establish
baselin
assess
treatment
respons
limit
howev
exist
mani
circumst
crosssect
imag
nonspecif
molecular
imag
fail
establish
diagnosi
avail
pathogenspecif
imag
agentsligand
would
great
effect
manag
patient
cn
infect
besid
earli
diagnosi
avoid
diagnost
brain
biopsi
signific
effect
mortal
morbid
patient
